Skip to content

news

Politico Pro – VALID Act left out of year-end omnibus

news

Pink Sheet – Genentech’s Xeloda Is First Label Updated Under OCE’s ‘Project Renewal’

news

360Dx – VALID, SALSA Still Unsettled as Legislative Deadline Approaches

news

The Washington Post – For new NCI director, work turns personal: She is diagnosed with cancer

news

InsideHealthPolicy – Pew, AdvaMed, Others Push For VALID As Clock Ticks On Govt. Funding

news

Politico Prescription Pulse – Market eyes coming Humira competition

publication

Statement by Friends of Cancer Research on the VALID Act of 2022

news

Statement by Friends of Cancer Research on the VALID Act of 2022

news

Stat Plus – Congress has a chance to close the FDA’s Theranos loophole

news

Pink Sheet – US FDA Oncology, Device Centers Developing Public Diagnostic Standards